FDA unconvinced by Sanofi’s Zynquista in type 1 diabetes
Company will also focus on serious chronic diseases
Device combination capable of recommending treatment decisions without finger-pricking.
System proven effective in children and adolescents as well as adults.
But still little progress on finding preventive treatments.
Four international trials will speed development of technology